AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

VREX · NASDAQ · Medical - Devices

Varex Imaging (VREX)

Builds X-ray imaging components for medical, security, cargo, and industrial systems.

$18.48

After hours+0.01 (+0.05%)

At close$18.47(0.00%)

In millions of USD, except per-share figures

In millions	Q4 FY23Sep 2023	Q1 FY24Dec 2023	Q2 FY24Mar 2024	Q3 FY24Jun 2024	Q4 FY24Sep 2024	Q1 FY25Jan 2025	Q2 FY25Apr 2025	Q3 FY25Jul 2025	Q4 FY25Oct 2025	Q1 FY26Jan 2026	Q2 FY26Apr 2026	Q3 FY26Jul 2026
Revenue	227	190	206	209	206	200	213	203	229	210	216	211
Cost of revenue	149	133	140	142	139	131	136	136	151	140	143	134
Gross profit	78	57	66	67	67	69	77	68	78	70	73	77
	54	53	58	58	56	57	55	148	58	54	58	54
Research & development	22	21	23	22	22	24	22	21	24	22	22	23
Selling, general & administrative	32	32	36	36	34	34	33	33	34	33	36	31
Other expenses	0	0	0	0	0	0	0	94	0	0	0	0
Operating income	24	4	8	9	11	11	22	−81	20	15	14	23
	−23	−5	−5	−9	−8	−9	−11	−6	−6	−12	−21	−7
Interest income	2	2	2	2	2	2	3	3	1	1	0	1
Interest expense	7	5	8	8	8	8	10	9	8	8	17	6
Other non-operating income	17	−1	0	3	1	1	1	−3	−2	4	4	1
Income before tax	1	−1	2	1	3	3	11	−87	14	4	−6	16
Income tax expense	−31	0	1	−1	52	3	4	3	2	1	2	0
Net income from continuing operations	32	0	2	2	−50	0	7	−89	12	2	−8	16
Net income	32	−1	1	1	−50	0	7	−89	12	2	−8	16
EPS, basic	$0.79	−$0.01	$0.03	$0.03	−$1.23	−$0.01	$0.17	−$2.15	$0.29	$0.06	−$0.19	$0.37
EPS, diluted	$0.63	−$0.01	$0.03	$0.03	−$1.23	−$0.01	$0.13	−$2.15	$0.29	$0.05	−$0.19	$0.37
Weighted average shares, basic	40	41	41	41	41	41	41	42	42	42	42	42
Weighted average shares, diluted	51	41	41	41	41	41	51	42	42	42	42	43
EBITDA	16	14	17	14	17	18	28	−71	29	19	18	22
Depreciation & amortization	9	9	9	7	7	7	7	7	7	7	7	0
EBIT	8	5	8	7	10	11	21	−78	22	12	11	22